QUINTA-ANALYTICA

Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+36...

Clinical studies,bioanalysis of small molecules,ba/be studies and phase 1,pharmacokinetic and toxicokinetic studies,analytical methods development,validation and transfer,extractables and leachables,impurities r&d,nitrosamine screening and quantification,formulation design,bioanalysis of large molecules,glp and gmp analyses of biopharmaceuticals,gmp quality control,release testing,stability studies,ich and on-going stability testing,analytics of biosimilars,characterizations of biopharmaceuticals,analytics of dry powder inhalers,microbiological testing,in vitro release and permeation testing,routine batch testing for release,api sourcing,and bacterial endotoxins

Quinta-analytica operates in the Pharmaceutical manufacturing industry.

Quinta-analytica's revenue is 11m - 100m

Quinta-analytica has 51 - 200 employees.